Join Zoom Meeting
https://mc-meet.zoom.us/j/95869608121?pwd=NG9GaG5JWE44eGpSckdRWHFSNnVkUT09
Meeting ID: 958 6960 8121
Passcode: 636276

Clinical Biochemistry
Alicia Algeciras-Schimnich, Ph.D.  
"Advances in Blood Based Biomarkers of Alzheimer's Disease"

Learning Objectives:
Upon conclusion of this activity, participants will be able to:

• Define the role of blood-based biomarkers (BBM) in the diagnosis of Alzheimer’s disease.
• Recognize the importance of performance measures when interpreting Alzheimer’s disease BBM.
• Identify the limitations of Alzheimer’s disease BBM.

Dr. Algeciras-Schimnich has the following relevant financial relationships to disclose Consulting: Fujirebio Diagnostics; Roche Diagnostics and intends to discuss the following off-label/investigative use of Pharmaceuticals or Instruments: Fujirebio Diagnostics – p-tau217 immunoassay.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.